Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men

Pathology International

Volumn 58, Issue 8, 2008, Pages 477-482

  Yanagawa, Naoki ^a   Osakabe, Mitsumasa ^a   Hayashi, Masahiro ^a   Tamura, Gen ^b   Motoyama, Teiichi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Yamagata Prefectural Central Hospital   (Japan)

Author keywords

HPV; Methylation; p53; Penile carcinoma

Indexed keywords

PROTEIN P53; VIRUS DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; JAPAN; MALE; METHYLATION; PENIS CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; VIRUS DETECTION; WART VIRUS;

ACID ANHYDRIDE HYDROLASES; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, SQUAMOUS CELL; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA METHYLATION; DNA, VIRAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MALE; MUTATION; NEOPLASM PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; RECEPTORS, RETINOIC ACID; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 46749142939     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02259.x     Document Type: Article

References (34)

1. Cubilla AL, Dillner J, Schelhammer PF et al. Tumors of the Penis. Malignant epithelial tumors. In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. World Health Organization Classification of Tumors. Pathology and Genetics. Tumors of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004 281 90.
2. Bosch FX, Lorincz A, Monoz N et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002 55: 244 65.
3. Osakabe M, Hayashi M, Katayama Y et al. Characteristics of vulvar squamous cell carcinoma in Japanese women. Pathol Int 2007 57: 322 7.
4. Rubin MA, Kleter B, Zhou M et al. Detection and typing of human papillomavirus DNA in penile carcinoma: Evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001 159: 1211 18.
5. zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002 2: 342 50.
6. Chan KW, Lam KY, Chan AC et al. Prevalence of human papillomavirus types 16 and 18 in penile carcinoma: A study of 41 cases using PCR. J Clin Pathol 1994 47: 823 6.
7. Cupp MR, Malek RS, Goellner JR et al. The detection of human papillomavirus deoxyribonucleic acid in intraepithelial, in situ, verrucous and invasive carcinoma of the penis. J Urol 1995 154: 1024 9.
8. Ferreux E, Lont AP, Horenblas S et al. Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J Pathol 2003 201: 109 18.
9. Gregoire L, Cubilla AL, Reuter VE et al. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J Natl Cancer Inst 1995 87: 1705 9.
10. Iwasawa A, Kumamoto Y, Fijinaga K. Detection of human papillomavirus deoxyribonucleic acid in penile carcinoma by polymerase chain reaction and in situ hybridization. J Urol 1993 149: 59 63.
11. Maden C, Sherman KJ, Beckmann AM et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 1993 85: 19 24.
12. Picconi MA, Eijan AM, Distefano AL et al. Human papillomavirus (HPV) DNA in penile carcinomas in Argentina: Analysis of primary tumors and lymph nodes. J Med Virol 2000 61: 65 9.
13. Young RH, Srigley JR, Amin MB et al. Tumors of the Prostate Gland, Seminal Vesicle, Male Urethra, and Penis. Atlas of Tumor Pathology, 3rd series, Fascicle 28. Washington, DC: Armed Forces Institute of Pathology, 2000.
14. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985 130: 118 26.
15. Yoshikawa H, Kawana T, Kitagawa K et al. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991 82: 524 31.
16. Jin Z, Ogata S, Tamura G et al. Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: A genetic study with special reference to histogenesis. Int J Gynecol Pathol 2003 22: 368 73.
17. Herman JG, Graff JR, Myohane S et al. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996 93: 9821 6.
18. Yanagawa N, Tamura G, Oizumi H et al. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 2003 94: 589 92.
19. Zochbauer-Muller S, Fong KM, Maitra A et al. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res 2001 61: 3581 5.
20. Zochbauer-Muller S, Fong KM, Virmani AK et al. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001 61: 249 55.
21. Suzuki H, Sato N, Kodama T et al. Detection of human papillomavirus DNA and state of p53 gene in Japanese penile cancer. Jpn J Clin Oncol 1994 24: 1 6.
22. Levi JE, Rahal P, Sarkis AS et al. Human papillomavirus DNA and p53 status in penile carcinomas. Int J Cancer 1998 76: 779 83.
23. Castrén K, Vähäkangas K, Heikkinen E et al. Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein. Int J Cancer 1998 77: 674 8.
24. Gentile V, Vicini P, Giacomelli L et al. Detection of human papillomavirus DNA, p53 and ki67 expression in penile carcinomas. Int J Immunopathol Pharmacol 2006 19: 209 15.
25. Lopes A, Bezerra AL, Pinto CA et al. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: Analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J Urol 2002 168: 81 6.
26. Lam KY, Chan AC, Chan KW et al. Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Eur J Surg Oncol 1995 21: 613 16.
27. Soufir N, Queille S, Liboutet M et al. Inactivation of the CDKN2A and the p53 tumour suppressor genes in external genital carcinomas and their precursors. Br J Dermatol 2007 156: 448 53.
28. Pekarsky Y, Zanesi N, Palamarchuk A et al. FHIT: From gene discovery to cancer treatment and prevention. Lancet Oncol 2002 3: 748 54.
29. Zochbauer-Muller S, Fong KM, Maitra A et al. 5′ CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res 2001 61: 3581 5.
30. Sozzi G, Pastorino U, Moiraghi L et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 1998 58: 5032 7.
31. Butler D, Collins C, Mabruk M et al. Loss of Fhit expression as a potential marker of malignant progression in preinvasive squamous cervical cancer. Gynecol Oncol 2002 86: 144 9.
32. Bae SC, Takahashi E, Zhang YW et al. Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain. Gene 1995 159: 245 8.
33. Kim TY, Lee HJ, Hwang KS et al. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest 2004 84: 479 84.
34. Li QL, Ito K, Sakakura C et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002 109: 113 24.